A detailed history of Royal Bank Of Canada transactions in Rx Sight, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 15,917 shares of RXST stock, worth $517,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,917
Previous 16,609 4.17%
Holding current value
$517,302
Previous $999,000 21.32%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.78 - $57.04 $28,219 - $39,471
-692 Reduced 4.17%
15,917 $786,000
Q2 2024

Aug 14, 2024

BUY
$50.42 - $64.29 $408,351 - $520,684
8,099 Added 95.17%
16,609 $999,000
Q1 2024

Nov 05, 2024

SELL
$35.51 - $57.92 $287,595 - $469,094
-8,099 Reduced 48.76%
8,510 $438,000
Q1 2024

May 15, 2024

SELL
$35.51 - $57.92 $128,404 - $209,438
-3,616 Reduced 29.82%
8,510 $438,000
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $167,844 - $328,304
8,027 Added 195.83%
12,126 $488,000
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $52,233 - $64,437
1,931 Added 89.07%
4,099 $114,000
Q2 2023

Aug 14, 2023

SELL
$16.37 - $28.9 $1,489 - $2,629
-91 Reduced 4.03%
2,168 $62,000
Q1 2023

May 15, 2023

SELL
$12.58 - $16.68 $20,593 - $27,305
-1,637 Reduced 42.02%
2,259 $37,000
Q4 2022

Feb 14, 2023

BUY
$9.93 - $14.2 $36,194 - $51,759
3,645 Added 1452.19%
3,896 $49,000
Q3 2022

Nov 14, 2022

BUY
$11.19 - $15.85 $1,510 - $2,139
135 Added 116.38%
251 $3,000
Q2 2022

Aug 15, 2022

SELL
$10.61 - $16.66 $10,206 - $16,026
-962 Reduced 89.24%
116 $2,000
Q1 2022

May 16, 2022

SELL
$8.97 - $14.03 $23,034 - $36,029
-2,568 Reduced 70.43%
1,078 $13,000
Q4 2021

Feb 14, 2022

BUY
$9.52 - $13.81 $9,824 - $14,251
1,032 Added 39.48%
3,646 $41,000
Q3 2021

Nov 15, 2021

BUY
$11.85 - $17.32 $30,975 - $45,274
2,614 New
2,614 $33,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $898M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.